UP

FDA: Pfizer vaccine 90.7% effective in kids aged 5-11

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The United States Food and Drug Administration (FDA) revealed on Friday its latest study found Pfizer Inc. and BioNTech SE's vaccine against COVID-19 is 90.7% effective against the disease in children aged between five and 11.

Axar.az reports that the trials were conducted in 2,268 individuals divided into two groups. Those that received both doses of the jab developed an immunity of 90.7% in comparison to those that got a placebo.

Pfizer asked for the FDA's approval for the use of its treatment in kids earlier this month.

Date
2021.10.22 / 20:31
Author
Axar.az
Comments
See also

WHO: Gaza's hospital not functional after Israel raids

This country is starting mass vaccination against fever

Urgent call from WHO on measles

The creator of the Sputnik V vaccine has died

Thousands of people died from coronavirus on the holiday

Uzbekistan develops edible COVID vaccine made from tomato

Infection has increased, use the mask! - Warning

Diseases could kill more than bombings in Gaza - WHO

A vaccine against cancer will be developed

World first: Human eye transplanted

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla